Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Responsive Industries Q1 FY20 earnings call: Revenue & Margins | Arthneeti

Q1 FY20

Consolidated: INR 146.44 Cr (Page 5) . Key concall takeaways from Responsive Industries Ltd's Q1 FY20 earnings call — and how it ranks against sector peers.

25 Sept 2026

Afcom Holdings Q3 FY25: Capex ₹8 Cr | Arthneeti

Q3 FY25

EBITDA for the quarter:** ₹ 7.9 Crores, up 33% year-on-year. Key concall takeaways from Afcom Holdings Ltd's Q3 FY25 earnings call — and how it ranks against…

25 Sept 2026

SMS Pharmaceuticals Q3 FY26: Revenue ₹210.45 Cr, PAT ₹23.47 Cr | Arthneeti

Q3 FY26

Q3FY26 Revenue from Operations: ₹210.45 crore, up 21% YoY (from ₹173.35 crore in Q3FY25) [Page 27] . Key concall takeaways from SMS Pharmaceuticals Ltd's Q3…

25 Sept 2026

TARC Q3 FY25: Revenue ₹9.35 Cr, PAT ₹28.69 Cr | Arthneeti

Q3 FY25

Q3 FY25 Revenue:** ₹9.35 crore, marginally up 0.48% YoY from ₹9.30 crore in Q3 FY24 (Page 20) . Key concall takeaways from TARC Ltd's Q3 FY25 earnings call…

25 Sept 2026

Responsive Industries Q1 FY19 earnings call: Revenue & Margins | Arthneeti

Q1 FY19

399 crores, down 45% year-on-year from Rs. Key concall takeaways from Responsive Industries Ltd's Q1 FY19 earnings call — and how it ranks against sector peers.

25 Sept 2026

Afcom Holdings Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

No explicit year-on-year growth or % change figures are stated in the slides . Key concall takeaways from Afcom Holdings Ltd's Q3 FY26 earnings call — and how…

25 Sept 2026

Afcom Holdings Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

EBITDA:** ₹78.34 crore, with a year-on-year (YoY) growth of 40.7%. Key concall takeaways from Afcom Holdings Ltd's Q1 FY26 earnings call — and how it ranks…

25 Sept 2026

SMS Pharmaceuticals Q1 FY27: Revenue ₹207 Cr, PAT ₹20 Cr | Arthneeti

Q1 FY27

Q1FY27 revenue from operations: ₹207 crore, up 6% YoY (Page 6, 5) . Key concall takeaways from SMS Pharmaceuticals Ltd's Q1 FY27 earnings call — and how it…

25 Sept 2026

SG Finserve Q1 FY25 earnings call: Revenue & Margins | Arthneeti

Q1 FY25

Interest Income for Q1 FY25: INR 42.83 crore, up 26% YoY from INR 34.07 crore in Q1 FY24. Key concall takeaways from SG Finserve Ltd's Q1 FY25 earnings call…

25 Sept 2026

SMS Pharmaceuticals Q3 FY25: Revenue ₹173.35 Cr, PAT ₹18.24 Cr | Arthneeti

Q3 FY25

Q3FY25 revenue from operations: ₹173.35 crore, up 7% YoY from ₹161.48 crore in Q3FY24 (Page 18, 5). Key concall takeaways from SMS Pharmaceuticals Ltd's Q3…

25 Sept 2026

SMS Pharmaceuticals Q1 FY26: Revenue ₹196.05 Cr, PAT ₹20.50 Cr | Arthneeti

Q1 FY26

Q1FY26 revenue from operations: ₹196.05 crore . Key concall takeaways from SMS Pharmaceuticals Ltd's Q1 FY26 earnings call — and how it ranks against sector…

25 Sept 2026

Tribhovandas Bhimji Zaveri Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

Q2 FY26 Revenue from operations: ₹6,878.28 million, up 21.30% YoY (from ₹5,670.47 million in Q2 FY25). Key concall takeaways from Tribhovandas Bhimji Zaveri…

25 Sept 2026

Tribhovandas Bhimji Zaveri Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Q4 FY25 revenue from operations: ₹5,293.43 million, a 4.51% increase YoY (Q4 FY24: ₹5,065.17 million) (Page 9, Page 8). Key concall takeaways from Tribhovandas…

25 Sept 2026

TARC Q1 FY27: Revenue ₹218.7 Cr, PAT ₹22.65 Cr | Arthneeti

Q1 FY27

Q1 FY2027 Revenue: ₹218.7 crore (up from ₹75.89 crore in Q1 FY2026), showing strong year-on-year growth. Key concall takeaways from TARC Ltd's Q1 FY27 earnings…

25 Sept 2026

Tribhovandas Bhimji Zaveri Q2 FY25 earnings call: Revenue & Margins | Arthneeti

Q2 FY25

Q2 FY25 revenue from operations: ₹5,670.47 million, a 17.99% YoY increase (Page 9, 8). Key concall takeaways from Tribhovandas Bhimji Zaveri Ltd's Q2 FY25…

25 Sept 2026

Tribhovandas Bhimji Zaveri Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Q4 FY26 revenue from operations: ₹8,296.95 million, up 56.74% YoY (Page 9, 8) . Key concall takeaways from Tribhovandas Bhimji Zaveri Ltd's Q4 FY26 earnings…

25 Sept 2026

TARC Q4 FY26: Revenue ₹300.02 Cr, PAT ₹1.61 Cr | Arthneeti

Q4 FY26

Q4 FY2026 Revenue:** ₹300.02 crore, sharply up from ₹13.89 crore in Q4 FY2025 (over 20x YoY growth). Key concall takeaways from TARC Ltd's Q4 FY26 earnings…

25 Sept 2026

TARC Q3 FY26: Revenue ₹1,000 Cr, EBITDA margin 33.77% | Arthneeti

Q3 FY26

Revenue for Q3 FY26: ₹38.38 lakhs vs ₹9.35 lakhs in Q3 FY25 (approx. Key concall takeaways from TARC Ltd's Q3 FY26 earnings call — and how it ranks against…

25 Sept 2026

TARC Q4 FY25: Revenue ₹3,722 Cr | Arthneeti

Q4 FY25

Sales in FY25 were ₹3,722 crore, up from ₹520 crore in FY23, representing over 7x growth in 2 years. Key concall takeaways from TARC Ltd's Q4 FY25 earnings…

25 Sept 2026

TARC Q2 FY26: Revenue ₹565 Cr, EBITDA margin 24.66% | Arthneeti

Q2 FY26

Q2 FY26 Revenue:** ₹687.06 lakhs, up 59.31% from ₹431.28 lakhs in Q2 FY25 . Key concall takeaways from TARC Ltd's Q2 FY26 earnings call — and how it ranks…

25 Sept 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access